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Using titrated oxygen instead of high ﬂow oxygen during 
an acute exacerbation of chronic obstructive pulmonary 
disease (COPD) saves lives
Synopsis
Summary of: Austin MA, et al (2010) Effect of high ﬂow 
oxygen on mortality in chronic obstructive pulmonary 
disease patients in prehospital setting: randomised 
controlled trial. BMJ 341: c5462. doi: 10.1136/bmj.c5462 
[Prepared by Kylie Hill, CAP Editor.]
Question: In patients with a suspected acute exacerbation 
of COPD, does titrated oxygen in the pre-hospital setting 
change mortality, length of hospital stay and blood gas 
measurements? Design: Cluster randomised controlled 
trial in which paramedics were allocated to deliver 
titrated or high ﬂow oxygen. Randomisation sequence 
was concealed prior to allocation. Setting: Ambulance 
service and emergency department in Hobart, Australia. 
Participants: People who were: transported by ambulance 
to the emergency department, aged ≥ 35 years, breathless, 
and were thought to have COPD based on their acute 
symptoms, a patient-stated history of COPD, or a smoking 
history of > 10 pack-years. Randomisation of 64 paramedics 
allocated 32 to the titrated oxygen group and 30 to the 
high ﬂow oxygen group. Over the study duration, 179 and 
226 patients were allocated to the titrated and high ﬂow 
oxygen groups, respectively. Interventions: Patients in both 
groups received basic support, nebulised bronchodilators, 
intravenous dexamethasone and, if necessary, intravenous 
or intramuscular salbutamol. In addition, the intervention 
group received titrated oxygen via nasal prongs, with the 
aim of maintaining arterial oxygen saturation, measured 
via a pulse oximeter (SpO2) between 88% and 92%. 
Nebulised therapy was delivered by compressed air. The 
control group received high ﬂow oxygen (8 to 10 L/min) 
via a non-rebreather face mask. Nebulised therapy was 
delivered by compressed oxygen at 6 to 8 L/min. Outcome 
measures: The primary outcome was pre-and in-hospital 
mortality. Secondary outcomes were length of hospital 
stay and blood gas measurements. Results: The primary 
outcome was captured for all enrolled patients. According 
to the intention to treat (ITT) analysis, mortality in the 
intervention and control groups was 4% (n = 7) and 9% 
(n = 21), respectively. The relative risk was 0.42 (95% CI 
0.20 to 0.89). Similar results were demonstrated when only 
those patients who had a physician-conﬁrmed diagnosis of 
COPD were included in the analyses (mortality of 2%, n 
= 2, vs 9%, n = 11, and relative risk of 0.22, 95% CI 0.05 
to 0.9]). The ITT analysis did not demonstrate between-
group differences in the secondary outcomes. Conclusion: 
In patients with a suspected acute exacerbation of COPD, 
using titrated oxygen to maintain SpO2 between 88% and 
92% reduced the risk of mortality by 58%. Physiotherapists 
working in acute care should strive to ensure that these 
patients are not treated with high-ﬂow oxygen.
Commentary
There is an increased risk of hypercarbia (Plant et al 2000) 
associated with the use of high levels of oxygen therapy in 
patients with COPD. High levels of oxygen are reported to 
cause increased ventilation perfusion mismatch (Sassoon et 
al 1987). National (McKenzie et al 2010) and international 
(O’Driscoll et al 2008) guidelines for the management 
of COPD recommend the controlled delivery of oxygen 
following an acute exacerbation of COPD with a target 
arterial oxygen saturation ranging between 88% and 92% 
(O’Driscoll et al 2008).
The trial by Austin et al (2010) provides the ﬁrst Level 1 
evidence that the pre-hospital short-term administration 
(45 minutes) of a high fraction of inspired oxygen during 
an acute exacerbation of COPD is associated with worse 
outcomes that include hypercarbia, respiratory acidosis, and 
increased mortality. Of note, the average partial pressure of 
arterial oxygen in the titrated oxygen therapy group was 80 
mmHg, in both the intention to treat and the protocol groups, 
which is considered excessive (O’Driscoll et al 2008), but 
this partial pressure still led to signiﬁcant improvements 
in patient outcome. Some authors recommend accepting 
an arterial saturation above 85% (New 2006) as a means 
of achieving better outcomes, but this requires appropriate 
investigation.
Titrated oxygen therapy to achieve arterial saturation 
of between 88% and 92% should be the goal of therapy 
by physiotherapists who care for patients during acute 
exacerbations of COPD. The close monitoring of changes 
in ventilation (carbon dioxide) in response to the delivery 
of oxygen therapy is also recommended. Further research 
is required to investigate the impact of oxygen therapy on 
respiratory function in patients during an acute exacerbation 
of COPD.
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